Consistently with the hypothesis of a therapeutic exploitation of the cAMP/PKA signaling pathway, Kang and colleagues also proposed the induction of growth arrest and forced neural differentiation via cAMP/PKA/CREB pathway in CD133-expressing GBM cancer stem cells as a new therapy for brain tumors [32]. The gene discussed is CREB1; the disease is glioblastoma.